Australian Postnatal Care Guidelines
Published by Living Evidence for Australian Pregnancy and Postnatal Care (LEAPP) on Dec 17, 2024
Disclaimer
Sponsors
This guideline is funded by the Australian Government Department of Health and Aged Care.
Australian Living Evidence Collaboration
School of Public Health and Preventive Medicine, Monash University, Level 4, 553 St Kilda Road, Melbourne, VIC 3004, Australia | ☏
made with
MAGIC
PICOS
PICO 10.1
Population
Women who are breastfeedingIntervention
Not consuming alcoholComparator
Consuming alcoholOutcomes
PICO 10.1
Population
Healthy mothers and term infantsIntervention
Early discharge (≤24 hours)Comparator
Standard or late dischargeOutcomes
PICO 10.2
Population
Healthy mothers and term infantsIntervention
Earlier (6-48h) first postnatal contact by midwifeComparator
Later (49-72h) first postnatal contact by midwifeOutcomes
PICO 10.3
Population
Healthy mothers and term infantsIntervention
Schedules involving more home visitsComparator
Schedules involving fewer home visitsOutcomes
PICO 10.4
Population
Healthy mothers and term infantsIntervention
Different models of careComparator
Standard models of careOutcomes
PICO 10.5
Population
Healthy mothers and term infantsIntervention
Home careComparator
Facility postnatal careOutcomes
PICO 20.1
Population
Postnatal womenIntervention
Validated depression assessment toolComparator
Any other tool or any scale of a given toolOutcomes
PICO 30.1
Population
Postnatal womenIntervention
Validated anxiety assessment toolComparator
Any other tool or any scale of a given toolOutcomes
PICO 40.1
Population
Women with preeclampsiaIntervention
Non steroidal anti-inflammatory drugsComparator
ParacetamolOutcomes
PICO 40.1
Population
Postnatal womenIntervention
Routine family violence screeningComparator
No screeningOutcomes
PICO 40.2
Population
Women with preeclampsiaIntervention
Routine use of loop diuretics in the postpartum periodComparator
PlaceboOutcomes
PICO 40.2
Population
Women disclosed family violenceIntervention
Post disclosure expectationComparator
NAOutcomes
PICO 40.3
Population
Women with preeclampsiaIntervention
Beta blockers (Labetalol 200–800 mg BD OR 100–1200 mg QID)Comparator
Calcium channel blockers (controlled release nifedipine 30–90 mg daily)Outcomes
PICO 40.3
Population
Perinatal womenIntervention
Any family violence screening toolComparator
Any alternative toolOutcomes
PICO 40.4
Population
Women with preeclampsiaIntervention
ACE-1 inhibitor (enalapril 5 mg daily for 1 week, 10 mg daily for 2 weeks and 20 mg daily maintenance dose)Comparator
PlaceboOutcomes
PICO 40.4
Population
Perinatal womenIntervention
Paper-pencil screeningComparator
Tablet based screeningOutcomes
PICO 40.5
Population
Women with preeclampsiaIntervention
ACE-I (captopril maximum of 150 mg daily)Comparator
Clonidine maximum of 0.6 mg dailyOutcomes
PICO 40.5
Population
Perinatal care providerIntervention
Training on FV screeningComparator
No training/pre-interventionOutcomes
PICO 50.1
Population
Postnatal womenIntervention
Validated psychosocial assessment toolComparator
Any other tool or any scale of a given toolOutcomes
View
made with
MAGIC